CURRENT ISSUE

Volume-IX

, Issue-II

(SPRING 2024)



01 - Evaluating Poly-Pharmacy and Drug Interactions in Cardiovascular Treatment: A Ca...

http://dx.doi.org/10.31703/gpsr.2024(IX-II).01
10.31703/gpsr.2024(IX-II).01      Published : Jun 2024

    Drug-drug interactions (DDIs) have a considerable impact on therapeutic response which, in turn, could result in adverse drug reactions (ADRs), or even treatment failure. It was directed at patients with cardiovascular diseases (CVDs) as this patient group is more likely to experience DDIs owing to the complexity and number of their drug treatments. The study, analyzed 108 prescriptions using diff... Details
    Cardiovascular Diseases, Drug-drug Interactions (DDI’s), Poly-pharmacy
    (1) Muhammad Adnan
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.
    (2) Savera Saghir
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.
    (3) Ejaz Ahmed
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.
    (4) Aimen Sahar
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.
    (5) Ahmad Jalal Masood
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.

02 - Exploring Oral Immunotherapeutics in Oncology: Uses, Side Effects Novel Approach...

http://dx.doi.org/10.31703/gpsr.2024(IX-II).02
10.31703/gpsr.2024(IX-II).02      Published : Jun 2024

    Immunotherapy is a medical intervention in which certain immune system components are used to combat disease. Usually, immunotherapy works by helping the body fight off the offending substance by modifying it as well as boosting the immune system. Biologic therapy or biotherapy are additional terms for certain forms of immunotherapy. Different advances and novel approaches have been studied such a... Details
    Cancer, ADCs, Immunotherapeutic, Oral Immunotherapeutic, Combination Therapies, Targeted Therapies, Adverse Effects, Challenges, Advancement in Immunotherapy
    (1) Kalya Ahmad Sandhu
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.
    (2) Asawar Yameen
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.
    (3) Naima Zafar
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.
    (4) Hira Ali
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.
    (5) Usama Abid
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.
    (6) Mishkaat Raza
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.